Hawthorn Medical Associates and Alexander Altschuller, MD, along with several of our other providers, are involved in several clinical trials and are currently enrolling participants.
Clinical trials are entirely voluntary and patients may withdraw consent at anytime, for any reason. Currently, we are participating in the following trials (follow links to learn more about each):
ALTITUDE
A randomized, double-blind, placebo-controlled, parallel-group study to determine whether, in patient with Type 2 Diabetes at high risk for cardiovascular and renal events, Aliskiren, on top of conventional treatment, reduces cardiovascular and renal morbidity and mortality
RED-HF
A double-blind randomized, placebo-controlled, multicenter study to assess the efficacy and safety of Darbepoetin alfa treatment on mortality and morbidity in heart failure (HF) subjects with symptomatic left ventricular systolic dysfunction and anemia
ROCHE
A randomized, double-blind, placebo-controlled study assessing the effect of RO4607381 on cardiovascular mortality and morbidity in clinically stable patients with a recent acute coronary syndrome
TOPCAT
Treatment of preserved cardiac function heart failure with an Aldosterone antagonist
TRA2P
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of SCH 530348 in addition to standard of care in subjects with a history of atherosclerotic disease: thrombin receptor antagonist in secondary prevention of atherthrombotic ischemic events (TRA2ºP-TIMI 50)
A Chance to Help Others and Yourself
